#Microbubbles or Ultrasound Contrast Agents Market Scope

[soumyafwr]

Microbubbles or Ultrasound Contrast Agents Market Overview, Competitive Analysis and Forecast 2031

[mordormr]

Exploring the Contrast Media Market: Growth Drivers, Trends, and Future Outlook

The contrast media market size is projected to be valued at USD 5.77 billion in 2024 and is anticipated to grow to USD 6.59 billion by 2029, with a compound annual growth rate (CAGR) of 7.44% over the forecast period from 2024 to 2029.

Market Overview and Growth Projections

The global contrast media market is on a robust growth trajectory, driven by a rising demand for diagnostic imaging procedures, increasing incidence of chronic diseases, and the need for early disease detection. Market research indicates a strong Compound Annual Growth Rate (CAGR) for the contrast media industry, with projections suggesting substantial expansion in the coming years.

Several key factors driving market growth include:

Increasing Prevalence of Chronic Diseases: Conditions such as cardiovascular diseases, cancer, and neurological disorders require sophisticated imaging for accurate diagnosis, elevating the need for contrast media.

Technological Advancements in Imaging: Innovations in MRI, CT, and ultrasound have expanded the scope and effectiveness of contrast agents, allowing for more detailed imaging and improving diagnostic accuracy.

Aging Population: As the global population ages, the demand for diagnostic procedures increases, leading to higher usage of contrast agents.

2. Market Segmentation

The contrast media market can be segmented by:

Type of Contrast Media: Including iodinated, barium-based, gadolinium-based, and microbubble contrast agents. Iodinated agents, widely used in CT scans, dominate the market.

Modality: The primary modalities that use contrast media include X-ray/CT, MRI, and ultrasound. Each modality has its specific type of contrast agent, with X-ray/CT being the largest segment.

Application: Applications range from cardiovascular imaging and oncology to neurology and musculoskeletal imaging.

With CT and MRI usage expanding in hospitals and clinics worldwide, the demand for iodinated and gadolinium-based contrast media remains high. However, the MRI segment is projected to witness faster growth due to its non-invasive nature and high accuracy.

3. Key Market Trends

Shift Toward Non-Ionic and Low-Osmolar Contrast Agents: These agents, designed to minimize side effects, are increasingly preferred in clinical settings, reducing the risk of adverse reactions in patients.

Increased Investment in Research and Development: With the rise in demand for safer and more effective agents, manufacturers are investing heavily in R&D. This investment aims to improve existing agents and develop innovative alternatives, including nanoparticle-based contrast agents.

Rising Demand for Injectable Contrast Agents: As these agents allow for better visualization, especially in vascular imaging, they’re increasingly used in procedures requiring high detail, such as cardiac and abdominal imaging.

Focus on Patient Safety and Regulatory Compliance: Given potential risks associated with some contrast agents, the industry is witnessing a trend toward products that ensure patient safety. Regulatory bodies play a critical role, as they set strict guidelines and approvals to maintain high safety standards.

Conclusion

As the demand for accurate and detailed diagnostic imaging rises, the contrast media market is positioned for impressive growth. The industry’s commitment to safety, innovation, and sustainability will likely drive future developments, ultimately leading to improved healthcare outcomes for patients around the world. For healthcare providers, staying informed on contrast media trends is essential to providing cutting-edge diagnostic services and enhancing patient care.

For a detailed overview and more insights, you can refer to the full market research report by Mordor Intelligence https://www.mordorintelligence.com/industry-reports/global-contrast-media-market-industry  

[chitrakullkarni]

Contrast Media/Contrast Agents Market Segmentation By Application, Regions, Trends, Share and Size

The global Contrast Media/Contrast Agents Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global Contrast Media/Contrast Agents market was valued at USD 4.25 Billion in 2016 and is expected to register a CAGR of 3.8% in the forecast period. The market is driven by factors such as rise in number of testing centers coupled with rise in number of government approvals for contrast agents. Increasing cases of cancer and rise in R&D activities add to the market growth in the forecast period. However, side effects and adverse reactions on health by use of Contrast Media/Contrast Agents are expected to restrict the market growth during the forecast period. Contrast Media market is segmented based on agent type, modality, application, and region. Type category for the market includes barium-based, gadolinium-based, microbubble and iodinated.

Key Players:

Bayer AG

General Electric Company

Guerbet

Lantheus Medical Imaging, Inc.

Bracco Diagnostics, Inc.

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/contrast-media-agents-market/request-sample

Growth Drivers:

Contrast agents are a crucial part of radiology and massive improvements have made them efficient, safer, and fast. On the other hand, associated risks led by Contrast Media/Contrast Agents remain prevalent and emit adverse reactions in various ways. Hence, the use of Contrast Media/Contrast Agents is subject to safe use acknowledging the potential side effects. Using contrast agents in a way such that it maximizes the patient’s safety is a great deal of concern. Therefore, the use of contrast agents must be determined on a particular basis depending to the clinical condition of the patient.

Application Outlook:

Cardiovascular disorders

Neurological disorders

Gastrointestinal disorders

Cancer

Nephrological disorders

Musculoskeletal disorders

Type Outlook:

Iodinated contrast media

Barium-based contrast media

Gadolinium-based contrast media

Microbubble contrast media

Modality Outlook:

X-ray/CT contrast agents

MRI contrast agents

Ultrasound contrast agents

Regional Outlook:

Geographical segmentation for Contrast Agents market spans North America, Latin America, Europe, Asia-Pacific, Middle East and Africa. North American market is expected to dominate the market in the forecast period due to government initiatives taken by key players coupled with presence of well-built healthcare infrastructure and availability of advanced technologies. In addition, constant demand for diagnostic procedures contribute to the market growth in the forecast period.

Rising investments coupled with active R&D activities is likely to propel the APAC’s market growth in the near future along with rise in cancer incidences, growth in investment in emerging economies adds to the market growth in APAC market sector.

Browse Related Category Research Reports @ https://blog.naver.com/tomclark

[swapnalisingh-blog]

Contrast Media Agents Market: Share, Market Size, Growth, Scope, Analysis And Forecast Report to 2027

The global contrast media agents market is expected to reach US$ 6,860.6 Mn in 2027 from US$ 4,855.2 Mn in 2018. The contrast media agents market is estimated to grow with a CAGR of 4.0% from 2019-2027.

 Request Sample Copy of this Report @ https://www.intelligencemarketresearch.com/ReportView?ReportID=11201907011003

The market is driven by the factors such as, increasing prevalence of chronic diseases, development in diagnostic imaging modalities coupled with rising numbers of diagnostic test procedures and increasing numbers of approvals for contrast agents. However, the factors such as side effects associated with contrast media agents and stringent regulations for radio imaging agents are expected to restrain the growth of market.

In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs. The rising prevalence of musculoskeletal diseases are the major factors of the market growth. For instance, according to Arthritis Foundation, in 2017, approximately 54 million adults have been diagnosed with arthritis. Almost 300,000 babies and children have arthritis or a rheumatic condition. The common type of arthritis is osteoarthritis, which affects approximately 31 million Americans. By the end of 2040, number of people expected to have doctor-diagnosed arthritis will be above 78 million.

 Ask for Discount @ https://www.intelligencemarketresearch.com/ReportEnquiry?ReportID=11201907011003&req_type=discount

Global contrast media agents market was segmented by type, imaging modality, indication and route of administration. The type segment was classified as iodinated contrast media, gadolinium based contrast media, barium-based contrast media, microbubble contrast media. Based on the imaging modality the market is classified as X-Ray/CT, magnetic resonance imaging and ultrasound. On the basis of indication the market is classified as cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, nephrological disorders. And based on the route of administration the market is divided into intravascular, oral and rectal. Some of the major primary and secondary sources included in the report for the contrast media agents market are World Health Organization, Dubai Health Authority, Canadian Cancer Society, Canadian Agency for Drugs and Technologies in Health, American Cancer Society, CBI Ministry of Foreign Affairs, Cancer Organization Soutien, Global Burden of Diseases, Entabeni Pretoria, South Africa and others.

 About Us –

Intelligence Market Research & Consulting, LLP (IMRC) is a global provider of research reports, business intelligence & consulting services. We know and understand the importance of market research data for your institution. Therefore, we have teamed up with the leading research institutes and strategy specialists to bring to you the latest, niche and most relevant statistical research.

Contact Us –

699, Butler St. Suite 1007

Saugatuck, MI - 49453, United States

Phone no.- +1 209 691 5657

Email id - sales@intelligencemarketresearch.com

Website -

www.intelligencemarketresearch.com

[thomasslobo-blog]

Global Medical Contrast Agent Market 2019 | Manufacturers In-Depth Analysis Report to 2024

The latest trending report Global Medical Contrast Agent Market 2019-2024 added by DecisionDatabases.com

Medical contrast agent is a material used in medical imaging to improve the contrast of structure or fluids inside a body. The contrast agents provide enhanced visibility for observation of blood vessels and the gastrointestinal tract. According to the imaging modalities such as x-ray and ultrasound, an array of contrast reagents is used as per requirement of the imaging technique.

The worldwide market for Medical Contrast Agent is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.

This report focuses on the Medical Contrast Agent in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/40685-medical-contrast-agent-industry-analysis-report

Market Segment by Manufacturers, this report covers

 GE Healthcare

 Bayer

 Bracco Imaging

 Guerbet Group

 Lantheus Medical Imaging

 Nanopet Pharma

 CMC Contrast

 Daiichi Sankyo

 Subhra Pharma Private

 Spago Nanomedical

Market Segment by Regions, regional analysis covers

 North America (United States, Canada and     Mexico)

 Europe (Germany, France, UK, Russia and     Italy)

 Asia-Pacific (China, Japan, Korea, India     and Southeast Asia)

 South America (Brazil, Argentina,     Colombia etc.)

 Middle East and Africa (Saudi Arabia,     UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

 Barium-based Contrast Media

 Iodinated Contrast Media

 Gadolinium-based Contrast Media

 Microbubble Contrast Media

Market Segment by Applications, can be divided into

 Cardiovascular Disorders

 Neurological Disorders

 Gastrointestinal Disorders

 Cancer

 Nephrological Disorders

 Musculoskeletal Disorders

 Other Applications

Download Free Sample Report of Global Medical Contrast Agent Market @ https://www.decisiondatabases.com/contact/download-sample-40685

The content of the study subjects, includes a total of 15 chapters: Chapter 1, to describe Medical Contrast Agent product scope, market overview, market opportunities, market driving force and market risks. Chapter 2, to profile the top manufacturers of Medical Contrast Agent, with price, sales, revenue and global market share of Medical Contrast Agent in 2017 and 2018. Chapter 3, the Medical Contrast Agent competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast. Chapter 4, the Medical Contrast Agent breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019. Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019. Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019. Chapter 12, Medical Contrast Agent market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. Chapter 13, 14 and 15, to describe Medical Contrast Agent sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Purchase the complete Global Medical Contrast Agent Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-40685

All Medical Devices Reports by DecisionDatabases.com @ https://goo.gl/wiaThb

About-Us: DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details: DecisionDatabases.com E-Mail: sales@decisiondatabases.com Phone: +91 9028057900 Web: https://www.decisiondatabases.com/

[pragya1-blog]

Diagnostic Imaging Agents Market Scope and Opportunities Analysis 2017- 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Obtain Report Details @

https://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

Request Report Brochure @

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Enquiry for Discount on this Report @

https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=20309

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research State Tower, 90 State Street, Suite 700 Albany, NY 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: www.transparencymarketresearch.com

[marketresearchreportinsight]

Microbubbles Contrast Agents Market Sales Channel, Distributors, Traders, Dealers, Appendix and Data Source 2022

Global Microbubbles Contrast Agents Market is expected to grow at a significant CAGR in the upcoming years as the scope and its applications are rising enormously across the globe. Microbubbles are used as ultrasound contrast agents as these are composed of gas core stabilized by a shell of polymers, proteins, or lipids and have a unique aptitude to respond to ultrasound. In cardiology and radiology, microbubbles are exclusively used for contrast ultrasound imaging as blood-pool agents.

The factors that are playing a major role in the growth of Microbubbles Contrast Agents Industry are the use of enhanced ultrasound technologies, cost-efficient, real-time capability of ultrasound images, and convenience. On the other hand, microbubbles do not last very long in circulation is a factor that may restrain overall market. Microbubbles Contrast Agents Market is segmented based on type, product types, applications, and region. Types such as Microbubble Gas Core and Microbubble Shell classify the market. Product types such as Perflutren, SonoVue, Perflexane Lipid Microspheres, and Optison classify Microbubbles Contrast Agents Industry.

View Full Report with TOC @ https://www.millioninsights.com/industry-reports/microbubbles-contrast-agents-market

Applications into Stem Cells Delivery, Molecular Imaging, Drug Delivery, Gene Therapy, Blood Volume and perfusion, Organ Edge Delineation, and others classify Microbubbles Contrast Agents Market. Microbubbles Contrast Agents Industry is segmented geographically into Americas (North America, Latin America), Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.

Market Segment:

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Microbubbles Contrast Agents in these regions, from 2012 to 2022 (forecast), covering

• North America

• Europe

• China

• Japan

• Southeast Asia

• India

Global Microbubbles Contrast Agents market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including

• Lantheus Medical Imaging, Inc.

• Bracco SpA

• GE Healthcare

• Daiichi Sankyo Company, Limited

• Bayer HealthCare AG

• Guerbet SA

The key players of Microbubbles Contrast Agents Industry are Guerbet SA, Lantheus Medical Imaging Inc., Bayer Healthcare AG, BraccoSpA, Daiichi Sankyo Company Ltd., and GE Healthcare. Globally, North America accounts for the largest market share of Microbubbles Contrast Agents Market and is estimated to lead the overall market in the years to come. Europe and the Asia Pacific follow suit. On the other hand, Asia Pacific is estimated to grow at fastest pace in the years to come. These players are concentrating on inorganic growth to sustain themselves amongst fierce competition. As such, mergers, acquisitions, and joint ventures are the need of the hour.

Request Sample Copy of This Report @ https://www.millioninsights.com/industry-reports/microbubbles-contrast-agents-market/request-sample

[fmi123-blog1]

Medical Imaging Agent-Producing System Market Assessment and Forecast Report by Future Market Insights  2018 – 2028

Pushing the boundaries of diagnostic approach

The rapidly expanding technological use of imaging techniques continues to push the boundaries of the diagnostic approach. Medical imaging is done in order to provide a scope of diagnostic and therapeutic approach towards the patient involved; using these techniques, doctors are able to diagnose diseases more precisely, and obtain a rather structural and functional imaging of the body. Medical imaging technologies allow a rapid diagnosis and evaluation of a wide range of pathologies. In order to increase their sensitivity and efficiency many imaging technologies rely on intravenously administered contrast agents. Imaging technologies like magnetic resonance imaging, computed tomography, surgical imaging, positron emission tomography and single-photon emission computed tomography are some of the major procedures practised in hospitals all over the globe due to its unparalleled look that they provide into the body. In order to assist healthcare professionals to visualize abnormalities in diagnostic image, contrast agents, materials that are used to reflect out visible changes on the resulting image are used. Contrast agents are of great meaning in diagnostic imaging as they provide a sensitive image technique allowing for the diagnosis of previously undetected complications. Through nano-scale manipulations new technologies for contrasting agents are on a rise, providing a more sensitive, biocompatible and bio-distribution profile of various contrast materials. Such advancements in the medical imaging agent follows new realms of imaging application such as fluorescence imaging.

Request for sample Report:https://www.futuremarketinsights.com/reports/sample/rep-gb-6710

Significance of medical imaging agent

Many imaging studies like MRI, CT and X-ray, involves the use imaging agents. Still, the contrast between the types of agent used in each procedure differs by how it performs in the respective target. The ability for a nanoparticle to identify the tissue of interest is perhaps the most vital character publicized. Through targeting; contrast agents can provide much more useful images by targeting tissues of interest, provide precise differences in tissue type and margins, which can help identify malignant and abnormal tissues much earlier. It has become possible to lower the dose given, reducing the expense and the toxic exposure of agent in the body. Furthermore, the image quality obtained can be improved with less contrasting agent floating free in the body resulting in improved signal to noise ratio.

Contrasting agents for different mode of operation

MRI Imaging agents: Gadolinium, contrast agent that is administered by injecting in the body to highlight areas of inflammation and tumour in MRI procedures. I.e., gadofosveset trisodium

CT imaging agents: X-ray and CT agents work by increasing the density of tissues targeted. They can be administered by mouth, enema or injection. I.e. iohexol, diatrizoate.

PET/SPECT imaging agents: Nuclear medicines used here provide information about tissue metabolism or some other specific change. The PET scanner detects the radiation and produces images of the body, many PET scanners include a CT scanner to allow image of both structure and its function. Useful to perform diagnosis and derive a required treatment. Required agents are radiopharmaceuticals which emits radiation in order to obtain image of the target tissue or organ.

Ultrasound imaging:  In order to visualize the micro-circulation in tissue, microbubble-based contrast agents are in use  I.e. Sulphur hexafluoride

Need of the hour

The medical imaging agent-producing systems market is driven by innovation in imaging modalities and advancements in imaging agents, growing awareness over the benefits of early diagnosis and the need for accurate and timely diagnosis especially among the aging population. Diagnostic and therapeutic procedures are carried out with a single medical approach of imaging which circles around the use of different available medical imaging agents.  Safety and efficacy issues are resulting in the migration away from traditional contrast agent towards a safer and vivid agents like the use of non-ionic monomeric contrast agents and iodinated contrast agents. Technology applied in medical imaging offers a lot and with progressive capital investment in transforming the heavy machinery promises to produce new advanced from of medical imaging, in turn, contrast agents. Owing to the increased demand, government across the globe are increasingly providing approvals for the use of different types of imaging agents. For instance, in May 2016, Bayer Healthcare received a FDA approval for their product used in magnetic resonance angiography (MRA) in the U.S. The global population getting diagnosed with a medical imaging support is enormous due to its efficiency and control, continuous advancement in the field provides an option for better application which can be readily available to more number of societies

Regional Market Outlook

Geographically, global medical imaging agent-producing systems market is segmented into eight key regions viz.  North America, Latin America, Western Europe, Eastern Europe, Asia Pacific (exc. Japan and China) ,Japan, China and Middle East & Africa. In North America, US majorly continues to dominate the global market as due to the high penetration of existing market among the end users and more number courses and imaging practices performed. Europe stores a greater no. of regional counterparts like Germany, France and united kingdom who shares a decent share of  medical imaging agent-producing systems market and is expected grow the market share in global medical imaging agent-producing systems market due its growing awareness. Asia Pacific (exc. Japan and China) due to its high population density, translating into more absolute need for treatments and is observed to be the market to grow majorly. Separate growth of small regional industries provides a broader outlook of the market.

Competition outlook

Some of the players identified in the global medical imaging agent-producing systems market are GE Healthcare, Bayer Healthcare Pharmaceuticals, Lantheus Medical Imaging , Bracco diagnostics, Elsai Co. and others. Focus on growing demand for efficient imaging agents for medical imaging will be rising in various developed countries and is expected to fuel the need for efficient research in other smaller sectors. Major players are producing systems which  provides an impactful procedure, increase patient compliance with dosing accuracy, convenience, safety and reduce patient time in healthcare centres. Companies are working in order to affiliate their system for mass usage and marketing, also opens up the market for smaller businesses to develop new technology around the contrast agents .With Increasing government funding for research in advanced medical treatment with concern to safety of patients is expected to drive the growth of global medical imaging agent-producing systems market.

Request for Brows-Full Report:https://www.futuremarketinsights.com/reports/medical-imaging-agent-producing-system-market

[soumyafwr]

Microbubbles or Ultrasound Contrast Agents Market Overview, Competitive Analysis and Forecast 2031

[healthy-insights]

Diagnostic Imaging Agents Market Research Report: Forecast up to 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

View Report-

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

 The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

 About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

 US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[healthy-insights]

Diagnostic Imaging Agents Market Research Report: Forecast up to 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

View Report-

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[healthy-insights]

Diagnostic Imaging Agents Market Research Report: Forecast up to 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

View Report-

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[healthy-insights]

Diagnostic Imaging Agents Market Research Report: Forecast up to 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

View Report-

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request a brochure of this report to know what opportunities will emerge in the rapidly evolving Diagnostic Imaging Agents Market during 2017- 2025

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com

[healthy-insights]

Diagnostic Imaging Agents Market: Key Players, Trends, Size, Share, Analysis, Estimations And Forecasts To 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Get Sample Copy of this Report @

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

View Report @ http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.  

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700 Albany, NY 12207 Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com

[healthy-insights]

Diagnostic Imaging Agents Market Research Report by Regional Analysis - North America, Europe, Asia Pacific, Latin America, Middle East & Africa : forecast 2025

Diagnostic imaging is a technique of producing visual representation of internal parts of the body. The diagnostic imaging technique is used for visualization of the function of internal organs, clinical analysis, and medical interventions. Diagnostic imaging helps to reveal internal picture hidden by the bones and skin and is used widely for diagnosing diseases and disorders. Radiology is a branch of medical science that uses diagnostic imaging to diagnose diseases within the human body. There are many imaging techniques such as X-ray radiography, computed tomography (CT), ultrasound, magnetic resonance imaging (MRI), and nuclear medicine, including positron emission tomography (PET). Diagnostic imaging agent is a substance administered to enhance contrast in the inside images of the body obtained using X-rays, gamma rays, sound waves, radio waves (MRI), or radioactive particles in order to diagnose diseases. The diagnostic imaging agents are commonly referred as contrast agents. Diagnostic imaging lacks visualization clarity which is peculiar, considering contrast agents have long been used with all imaging techniques. In general, the contrasting agent works on the principle with determining echo scattering in all cases of diagnostic imaging techniques.

Developed and introduced microbubble contrast agents are safe and effective in clinical practice, which are likely to open new opportunities for the global diagnostic imaging agents market. In addition, increase in number of diagnostic procedures with growing medical infrastructure is anticipated to drive the global market during the forecast period. Omnipaque, Visipaque, Iopamiron, Ultravist, and Cardiolite are the highest selling diagnostic imaging agents present in the market. Ideally, imaging agents should have characteristics such as selectivity for biochemical targets, good ratio of specific to non-specific binding, better safety profile, and signal amplification capabilities. However, high costs and significant break in the development of imaging agents for commercialization are estimated to limit the growth of the global market. The market growth is likely to get slower as long as the issue of commercialization of diagnostic imaging agents are not addressed.

Browse full report on Diagnostic Imaging Agents Market -

http://www.transparencymarketresearch.com/diagnostic-imaging-agents-market.html

The global diagnostic imaging agents market has been segmented on the basis of type, route of administration, procedure, application, and geography. In terms of type, the market is classified into ionic and nonionic imaging agents which consist of barium-based imaging agents, iodinated imaging agents, gadolinium-based imaging agents, and microbubble contrast media. The iodinated imaging agents segment is estimated to drive the growth of the market owing to high volume globally. Based on route of administration, the global market is classified into oral, rectal, urethral, and parenteral. Increase in use of injectable in various procedures such as X-ray, CT scan, MRI, and ultrasound are expected to drive this segment of the market. Based on procedure, the global diagnostic imaging agents market has been classified into X-ray imaging agents, CT scan imaging agents, MRI imaging agents, and ultrasound imaging agents. The high number of approvals for ultrasound contrast media in various markets is a key factor driving the growth of this segment. Based on application, the global market has been divided into radiology, interventional cardiology, and interventional radiology. The radiology segment is estimated to contribute a high share of the market owing to increase in number of diagnostic procedures.

Geographically, the global diagnostic imaging agents market is segmented into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America is estimated to dominate the global diagnostic imaging agents market during the forecast period owing to developed health care infrastructure and high number of diagnostic procedures. Europe is expected to be the second leading market during the forecast period globally. India, China, and Japan are the developing countries in Asia Pacific, and hence fuel the growth of the Asia Pacific market.

The major players operating in the global diagnostic imaging agents market include GE Healthcare, Bayer HealthCare, Daiichi Sankyo Company, Limited, Eisai Co., Ltd., Aytu BioSciences, Inc., Guerbet Group, and Bracco Imaging S.p.A.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Request for brochure of this report -

http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20309

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700

Albany, NY 12207

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com